BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 18814264)

  • 21. Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3.
    Chen W; Jin W; Hardegen N; Lei KJ; Li L; Marinos N; McGrady G; Wahl SM
    J Exp Med; 2003 Dec; 198(12):1875-86. PubMed ID: 14676299
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Demonstration of circulating allergen-specific CD4+CD25highFoxp3+ T-regulatory cells in both nonatopic and atopic individuals.
    Maggi L; Santarlasci V; Liotta F; Frosali F; Angeli R; Cosmi L; Maggi E; Romagnani S; Annunziato F
    J Allergy Clin Immunol; 2007 Aug; 120(2):429-36. PubMed ID: 17604089
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Low-dose splenic radiation inhibits liver tumor development of rats through functional changes in CD4+CD25+Treg cells.
    Wang B; Li B; Dai Z; Ren S; Bai M; Wang Z; Li Z; Lin S; Wang Z; Huang N; Yang P; Liu M; Min W; Ma H
    Int J Biochem Cell Biol; 2014 Oct; 55():98-108. PubMed ID: 25168696
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Generation of human Th1-like regulatory CD4+ T cells by an intrinsic IFN-γ- and T-bet-dependent pathway.
    Zheng J; Liu Y; Qin G; Lam KT; Guan J; Xiang Z; Lewis DB; Lau YL; Tu W
    Eur J Immunol; 2011 Jan; 41(1):128-39. PubMed ID: 21182084
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CD4+FoxP3+ regulatory T cells gradually accumulate in gliomas during tumor growth and efficiently suppress antiglioma immune responses in vivo.
    Grauer OM; Nierkens S; Bennink E; Toonen LW; Boon L; Wesseling P; Sutmuller RP; Adema GJ
    Int J Cancer; 2007 Jul; 121(1):95-105. PubMed ID: 17315190
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epigenetic inheritance of DNA methylation limits activation-induced expression of FOXP3 in conventional human CD25-CD4+ T cells.
    Nagar M; Vernitsky H; Cohen Y; Dominissini D; Berkun Y; Rechavi G; Amariglio N; Goldstein I
    Int Immunol; 2008 Aug; 20(8):1041-55. PubMed ID: 18567616
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased Foxp3(+) Treg cell activity reduces dendritic cell co-stimulatory molecule expression in aged mice.
    Chiu BC; Stolberg VR; Zhang H; Chensue SW
    Mech Ageing Dev; 2007; 128(11-12):618-27. PubMed ID: 17961632
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Changes of CD4+CD25+Foxp3+ regulatory T cells in aged Balb/c mice.
    Zhao L; Sun L; Wang H; Ma H; Liu G; Zhao Y
    J Leukoc Biol; 2007 Jun; 81(6):1386-94. PubMed ID: 17369496
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immune compartmentalization of T cell subsets in chemically-induced breast cancer.
    Fahmi T; Esendagli G; Yilmaz G; Kansu E; Guc D
    Scand J Immunol; 2010 Oct; 72(4):339-48. PubMed ID: 20883319
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intravenous immunoglobulin attenuates airway inflammation through induction of forkhead box protein 3-positive regulatory T cells.
    Massoud AH; Guay J; Shalaby KH; Bjur E; Ablona A; Chan D; Nouhi Y; McCusker CT; Mourad MW; Piccirillo CA; Mazer BD
    J Allergy Clin Immunol; 2012 Jun; 129(6):1656-65.e3. PubMed ID: 22564681
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Delta-like 1-mediated Notch signaling enhances the in vitro conversion of human memory CD4 T cells into FOXP3-expressing regulatory T cells.
    Mota C; Nunes-Silva V; Pires AR; Matoso P; Victorino RM; Sousa AE; Caramalho I
    J Immunol; 2014 Dec; 193(12):5854-62. PubMed ID: 25367118
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of immunosuppressive drug rapamycin on regulatory CD4+CD25+Foxp3+T cells in mice.
    Qu Y; Zhang B; Zhao L; Liu G; Ma H; Rao E; Zeng C; Zhao Y
    Transpl Immunol; 2007 Apr; 17(3):153-61. PubMed ID: 17331841
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Induction of regulatory T cells by physiological level estrogen.
    Tai P; Wang J; Jin H; Song X; Yan J; Kang Y; Zhao L; An X; Du X; Chen X; Wang S; Xia G; Wang B
    J Cell Physiol; 2008 Feb; 214(2):456-64. PubMed ID: 17654501
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Downregulation of CD4+CD25+ regulatory T cells may underlie enhanced Th1 immunity caused by immunization with activated autologous T cells.
    Cao Q; Wang L; Du F; Sheng H; Zhang Y; Wu J; Shen B; Shen T; Zhang J; Li D; Li N
    Cell Res; 2007 Jul; 17(7):627-37. PubMed ID: 17563757
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neuropilin-1 is not a marker of human Foxp3+ Treg.
    Milpied P; Renand A; Bruneau J; Mendes-da-Cruz DA; Jacquelin S; Asnafi V; Rubio MT; MacIntyre E; Lepelletier Y; Hermine O
    Eur J Immunol; 2009 Jun; 39(6):1466-71. PubMed ID: 19499532
    [TBL] [Abstract][Full Text] [Related]  

  • 36. FOXP3+CD25- tumor cells with regulatory function in Sézary syndrome.
    Heid JB; Schmidt A; Oberle N; Goerdt S; Krammer PH; Suri-Payer E; Klemke CD
    J Invest Dermatol; 2009 Dec; 129(12):2875-85. PubMed ID: 19626037
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Subpopulations of equine blood lymphocytes expressing regulatory T cell markers.
    Robbin MG; Wagner B; Noronha LE; Antczak DF; de Mestre AM
    Vet Immunol Immunopathol; 2011 Mar; 140(1-2):90-101. PubMed ID: 21208665
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The significantly enhanced frequency of functional CD4+CD25+Foxp3+ T regulatory cells in therapeutic dose aspirin-treated mice.
    Javeed A; Zhang B; Qu Y; Zhang A; Sun C; Zhang L; Liu J; Zeng C; Zhao Y
    Transpl Immunol; 2009 Mar; 20(4):253-60. PubMed ID: 19146957
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Primary cutaneous T-cell lymphoma expressing FOXP3: a case report supporting the existence of malignancies of regulatory T cells.
    Marzano AV; Vezzoli P; Fanoni D; Venegoni L; Berti E
    J Am Acad Dermatol; 2009 Aug; 61(2):348-55. PubMed ID: 19615546
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of dendritic cell subpopulations in follicular lymphoma with respect to the tumor immune microenvironment.
    Chevalier N; Mueller M; Mougiakakos D; Ihorst G; Marks R; Schmitt-Graeff A; Veelken H
    Leuk Lymphoma; 2016 Sep; 57(9):2150-60. PubMed ID: 26757600
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.